Abstract Background Lipoprotein (a)[Lp (a)] is associated with increased risk of myocardial
infarction, although the mechanism for this observation remains uncertain. Objectives This …

In pivotal clinical effectiveness trials, the primary endpoint needs to be precisely defined and
quantified because any misclassification could introduce noise and possible bias, potentially …

Background: Type 2 myocardial infarction is caused by myocardial oxygen supply-demand
imbalance, and its diagnosis is increasingly common with the advent of high-sensitivity …

Importance Recurrent coronary events in patients with recent myocardial infarction remain a
major clinical problem. Noninvasive measures of coronary atherosclerotic disease activity …

Background Positron emission tomography (PET) using 18F-sodium fluoride (18F-fluoride)
to detect microcalcification may provide insight into disease activity in coronary …

Coronary 18F-sodium fluoride (18F-NaF) PET and CT angiography–based quantitative
plaque analysis have shown promise in refining risk stratification in patients with coronary …

Objectives The aim of this study was to describe the potential of 18F-sodium fluoride (18F-
NaF) positron emission tomography (PET) to identify graft vasculopathy and to investigate …

Background: Assessments of coronary disease activity with 18F-sodium fluoride positron
emission tomography and radiomics-based precision coronary plaque phenotyping derived …

Background In patients with stable chest pain, computed tomography (CT) plaque burden is
an independent predictor of future coronary events. Objectives The purpose of this study …

Cardiovascular disease remains a major cause of mortality, accounting for a third of all
global deaths annually. Although there have been major improvements in our ability to …